- Home
- CLRB vs HTCR Comparison
CLRB vs HTCR Comparison
Compare CLRB & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- HTCR
- Stock Information
- Founded
- CLRB 2002
- HTCR 2009
- Country
- CLRB United States
- HTCR Japan
- Employees
- CLRB N/A
- HTCR N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- HTCR EDP Services
- Sector
- CLRB Health Care
- HTCR Technology
- Exchange
- CLRB Nasdaq
- HTCR Nasdaq
- Market Cap
- CLRB 12.5M
- HTCR 12.8M
- IPO Year
- CLRB N/A
- HTCR 2022
- Fundamental
- Price
- CLRB $7.90
- HTCR $0.52
- Analyst Decision
- CLRB Hold
- HTCR
- Analyst Count
- CLRB 2
- HTCR 0
- Target Price
- CLRB N/A
- HTCR N/A
- AVG Volume (30 Days)
- CLRB 1.3M
- HTCR 194.5K
- Earning Date
- CLRB 08-12-2025
- HTCR 08-13-2025
- Dividend Yield
- CLRB N/A
- HTCR 3.92%
- EPS Growth
- CLRB N/A
- HTCR N/A
- EPS
- CLRB N/A
- HTCR N/A
- Revenue
- CLRB N/A
- HTCR $28,947,523.00
- Revenue This Year
- CLRB N/A
- HTCR N/A
- Revenue Next Year
- CLRB N/A
- HTCR $8.59
- P/E Ratio
- CLRB N/A
- HTCR N/A
- Revenue Growth
- CLRB N/A
- HTCR 59.42
- 52 Week Low
- CLRB $6.50
- HTCR $0.49
- 52 Week High
- CLRB $94.50
- HTCR $3.38
- Technical
- Relative Strength Index (RSI)
- CLRB 40.04
- HTCR 44.82
- Support Level
- CLRB $9.60
- HTCR $0.54
- Resistance Level
- CLRB $10.19
- HTCR $0.55
- Average True Range (ATR)
- CLRB 1.57
- HTCR 0.03
- MACD
- CLRB -0.50
- HTCR 0.00
- Stochastic Oscillator
- CLRB 11.58
- HTCR 44.83
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About HTCR Heartcore Enterprises Inc.
HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.